These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 76845)

  • 21. Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
    Arze RS; Parkinson IS; Cartlidge NE; Britton P; Ward MK
    Lancet; 1981 Nov; 2(8255):1116. PubMed ID: 6118567
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.
    Fleming LW; Stewart Wk; Fell GS; Halls DJ
    Clin Nephrol; 1982 May; 17(5):222-7. PubMed ID: 7094439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical concentrations of aluminium in water used for dialysis.
    Hodge KC; Day JP; O'Hara M; Ackrill P; Ralston AJ
    Lancet; 1981 Oct; 2(8250):802-3. PubMed ID: 6116918
    [No Abstract]   [Full Text] [Related]  

  • 24. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG; Nielsen LP
    Miner Electrolyte Metab; 1984; 10(6):345-50. PubMed ID: 6503890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)].
    Galle P; Chatel M; Berry JP; Menault F
    Nouv Presse Med; 1979 Dec; 8(50):4091-4. PubMed ID: 530824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low aluminium water, desferrioxamine, and dialysis encephalopathy.
    Milne FJ; Sharf B; Bell PD; Meyers AM
    Lancet; 1982 Aug; 2(8296):502. PubMed ID: 6125670
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Lafforgue B; Raymond P; Jaudon MC
    Nouv Presse Med; 1978 Jun; 7(23):2053-9. PubMed ID: 673773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Aluminium and dialysis encephalopathy.
    Platts MM; Hislop JS
    Lancet; 1976 Jul; 2(7976):98. PubMed ID: 59177
    [No Abstract]   [Full Text] [Related]  

  • 31. Dialysis dementia, aluminium, and tetrahydrobiopterin metabolism.
    Bone I; Thomas M
    Lancet; 1979 Apr; 1(8119):782. PubMed ID: 86025
    [No Abstract]   [Full Text] [Related]  

  • 32. [Encephalopathy in patients treated by hemodialysis as a psychiatric problem].
    Pilaczyńska E
    Psychiatr Pol; 1985; 19(5):387-95. PubMed ID: 3913979
    [No Abstract]   [Full Text] [Related]  

  • 33. [Water purification in dialysis treatment. Aluminum and encephalopathy].
    Hagstam KE; Lindergård B; Lindholm T; Thysell H
    Lakartidningen; 1980 Jun; 77(26-27):2425-7. PubMed ID: 7401791
    [No Abstract]   [Full Text] [Related]  

  • 34. Aluminium encephalopathy.
    Bates D; Parkinson IM; Ward MK; Kerr DN
    Contrib Nephrol; 1985; 45():29-41. PubMed ID: 3979053
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Mashaly R; Jaudon MC; Lafforgue B; Lebkiri B; Raymond P
    Nouv Presse Med; 1979 Sep; 8(34):2729-33. PubMed ID: 493078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre: evidence for "safe" upper limit of aluminium in water.
    Platts MM; Owen G; Smith S
    Br Med J (Clin Res Ed); 1984 Mar; 288(6422):969-72. PubMed ID: 6423163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
    Mudde AH; Roodvoets AP; Van Groningen K
    Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.
    Mazzeo-Farina A; Cerulli N
    Clin Chim Acta; 1985 Apr; 147(3):247-54. PubMed ID: 3995774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients.
    Morris CM; Candy JM; Oakley AE; Taylor GA; Mountfort S; Bishop H; Ward MK; Bloxham CA; Edwardson JA
    J Neurol Sci; 1989 Dec; 94(1-3):295-306. PubMed ID: 2614472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysis encephalopathy.
    Masramón J; Ricart MJ; Caralps A; Lloveras J; Andreu J; Brulles A; Solá R
    Lancet; 1978 Jun; 1(8078):1370. PubMed ID: 78143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.